| Name | Title | Contact Details |
|---|---|---|
Auste Graham |
Vice President- Legal, Americas | Profile |
Pendrick Capital Partners is one of the largest HEALTHCARE debt buyers in the USA providing additional revenue streams to all our clients. Our management team is comprised of industry veterans with over 80 years of combined knowledge. We bring core expertise to all consumer debt segments in our underwriting and servicing processes. We hold ourselves to the highest standards and take pride in our business relationships. Our commitment to customer service is unmatched in the industry, just ask for our references. The sale of aged A/R among HEALTHCARE providers has become much more mainstream over the last 10 years. During the last 3 years, Pendrick Capital Partners has purchased over 55 million accounts with a face value of over $16 billion. These portfolios represent patient accounts at ER physician groups, ambulance companies and hospitals. The desire of providers to implement a profitable, compliant, and sensible solution to their revenue cycle challenges and cash acceleration needs has never been greater. With the right partner, the impact of selling should be no different than the impact of using contingency collection agencies to recover delinquent accounts. In many cases, clients have informed us that this practice has enhanced overall collections, as it creates an expectation of payment within their patient bases. Pendrick Capital Partners recognizes the important role that physicians, clinics and hospitals play in local communities and conducts its business with the highest degree of professionalism and respect for patients and clients. Careful due diligence helps us understand an organization`s unique needs and ensures that our tailored collection efforts meet our clients expectations prior to starting a relationship. We do not resell accounts and strongly recommend that any healthcare provider who is concerned about patient and community relations makes a no-resale provision a non-negotiable part of its business agreement with any debt buyer.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Alliance Machine Systems International LLC is the global source of innovative products and services to enhance the efficiency and performance of the corrugated packaging industry. The company continuously strives to provide customers with an ever-broadening line of products and services through investments in R&D, training, strategic acquisitions and partnerships. For more than 40 years, Spokane Valley, Washington-based Alliance has designed and manufactured more than 14,000 machines for the corrugated industry, with installations worldwide. Alliance offers material handling systems that keep pace with todays faster finishing machines. It offers high-speed feeding and downstream handling designs that are reliable, cost-effective solutions to increasing productivity. Products include robotic loadformers, stackers, prefeeders, pallet handlers, specialty folder gluers, and more.
Over 30 years ago, artist and designer Christopher Farr set out to unite heritage textile craftsmanship with contemporary design vision. Since then, he and his business partner Matthew Bourne have maintained a dedication to quality and an uncompromising pursuit of beauty that has helped revolutionise rug design and restore rug-making to the status of fine art. Each one made to order, Christopher Farr rugs are now a frequent sight at global art and design exhibitions, and in the homes of connoisseurs and collectors worldwide. Christopher Farr continues to protect and preserve the worlds weaving traditions, while pushing at the creative possibilities of design. Alongside Christophers own work, the company collaborates with a considered roster of international artists, architects, fashion designers and other visionaries to produce a selection of designs that remains unrivalled in its creative scope. Distribution is through showrooms located in London and Los Angeles as well as representation throughout the world. Collections include bespoke collaborations with designers such as Andrée Putman and John Pawson and artists including Gary Hume and Makoto Kagoshima. CF Editions collaborates with some of the worlds leading artists and designers, both past and present, including Josef and Anni Albers, Gunta Stölzl, Terry Frost and Sandra Blow. All designs are produced with the relevant institution, art gallery, estate or artist closely involved in the whole process and every rug is delivered with a signed certificate of authenticity. Unlike the made to order rugs, Editions are in stock and ready for delivery.